Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

CRESY vs BIOX

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CRESY
Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria

Conglomerates

IndustrialsNASDAQ • AR
Market Cap$747M
5Y Perf.+274.7%
BIOX
Bioceres Crop Solutions Corp.

Agricultural Inputs

Basic MaterialsNASDAQ • AR
Market Cap$31M
5Y Perf.-92.8%

CRESY vs BIOX — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CRESY logoCRESY
BIOX logoBIOX
IndustryConglomeratesAgricultural Inputs
Market Cap$747M$31M
Revenue (TTM)$1.05T$318M
Net Income (TTM)$234.51B$-53M
Gross Margin42.0%39.1%
Operating Margin62.1%0.2%
Forward P/E9999.0x
Total Debt$1.46T$277M
Cash & Equiv.$250.85B$33M

CRESY vs BIOXLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CRESY
BIOX
StockMay 20May 26Return
Cresud Sociedad Anó… (CRESY)100374.7+274.7%
Bioceres Crop Solut… (BIOX)1007.2-92.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: CRESY vs BIOX

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CRESY leads in 6 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Bioceres Crop Solutions Corp. is the stronger pick specifically for valuation and capital efficiency. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
CRESY
Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria
The Income Pick

CRESY carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 0 yrs, beta 1.19, yield 8.2%
  • Rev growth 28.5%, EPS growth -99.9%, 3Y rev CAGR 6.0%
  • 68.4% 10Y total return vs BIOX's -95.0%
Best for: income & stability and growth exposure
BIOX
Bioceres Crop Solutions Corp.
The Value Play

BIOX is the clearest fit if your priority is value.

  • Better valuation composite
Best for: value
See the full category breakdown
CategoryWinnerWhy
GrowthCRESY logoCRESY28.5% revenue growth vs BIOX's -28.3%
ValueBIOX logoBIOXBetter valuation composite
Quality / MarginsCRESY logoCRESY22.3% margin vs BIOX's -16.6%
Stability / SafetyCRESY logoCRESYBeta 1.19 vs BIOX's 1.94, lower leverage
DividendsCRESY logoCRESY8.2% yield; the other pay no meaningful dividend
Momentum (1Y)CRESY logoCRESY+13.6% vs BIOX's -88.4%
Efficiency (ROA)CRESY logoCRESY4.3% ROA vs BIOX's -6.7%, ROIC 5.7% vs -0.5%

CRESY vs BIOX — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCRESYLAGGINGBIOX

Income & Cash Flow (Last 12 Months)

CRESY leads this category, winning 5 of 6 comparable metrics.

CRESY is the larger business by revenue, generating $1.05T annually — 3307.4x BIOX's $318M. CRESY is the more profitable business, keeping 22.3% of every revenue dollar as net income compared to BIOX's -16.6%. On growth, CRESY holds the edge at +50.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricCRESY logoCRESYCresud Sociedad A…BIOX logoBIOXBioceres Crop Sol…
RevenueTrailing 12 months$1.05T$318M
EBITDAEarnings before interest/tax$670.2B$21M
Net IncomeAfter-tax profit$234.5B-$53M
Free Cash FlowCash after capex$116.8B$37M
Gross MarginGross profit ÷ Revenue+42.0%+39.1%
Operating MarginEBIT ÷ Revenue+62.1%+0.2%
Net MarginNet income ÷ Revenue+22.3%-16.6%
FCF MarginFCF ÷ Revenue+11.1%+11.5%
Rev. Growth (YoY)Latest quarter vs prior year+50.4%-16.4%
EPS Growth (YoY)Latest quarter vs prior year+2.6%-37.3%
CRESY leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

BIOX leads this category, winning 4 of 5 comparable metrics.

On an enterprise value basis, CRESY's 9.7x EV/EBITDA is more attractive than BIOX's 20.0x.

MetricCRESY logoCRESYCresud Sociedad A…BIOX logoBIOXBioceres Crop Sol…
Market CapShares × price$747M$31M
Enterprise ValueMkt cap + debt − cash$1.6B$275M
Trailing P/EPrice ÷ TTM EPS9999.00x-0.59x
Forward P/EPrice ÷ next-FY EPS est.
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple9.73x20.05x
Price / SalesMarket cap ÷ Revenue1.14x0.09x
Price / BookPrice ÷ Book value/share0.48x0.10x
Price / FCFMarket cap ÷ FCF9.85x0.87x
BIOX leads this category, winning 4 of 5 comparable metrics.

Profitability & Efficiency

CRESY leads this category, winning 7 of 9 comparable metrics.

CRESY delivers a 10.1% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-17 for BIOX. CRESY carries lower financial leverage with a 0.66x debt-to-equity ratio, signaling a more conservative balance sheet compared to BIOX's 0.94x. On the Piotroski fundamental quality scale (0–9), CRESY scores 5/9 vs BIOX's 3/9, reflecting solid financial health.

MetricCRESY logoCRESYCresud Sociedad A…BIOX logoBIOXBioceres Crop Sol…
ROE (TTM)Return on equity+10.1%-16.7%
ROA (TTM)Return on assets+4.3%-6.7%
ROICReturn on invested capital+5.7%-0.5%
ROCEReturn on capital employed+6.4%-0.8%
Piotroski ScoreFundamental quality 0–953
Debt / EquityFinancial leverage0.66x0.94x
Net DebtTotal debt minus cash$1.21T$244M
Cash & Equiv.Liquid assets$250.9B$33M
Total DebtShort + long-term debt$1.46T$277M
Interest CoverageEBIT ÷ Interest expense3.48x-0.07x
CRESY leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

CRESY leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in CRESY five years ago would be worth $24,972 today (with dividends reinvested), compared to $321 for BIOX. Over the past 12 months, CRESY leads with a +13.6% total return vs BIOX's -88.4%. The 3-year compound annual growth rate (CAGR) favors CRESY at 35.0% vs BIOX's -63.7% — a key indicator of consistent wealth creation.

MetricCRESY logoCRESYCresud Sociedad A…BIOX logoBIOXBioceres Crop Sol…
YTD ReturnYear-to-date-6.9%-64.3%
1-Year ReturnPast 12 months+13.6%-88.4%
3-Year ReturnCumulative with dividends+146.2%-95.2%
5-Year ReturnCumulative with dividends+149.7%-96.8%
10-Year ReturnCumulative with dividends+68.4%-95.0%
CAGR (3Y)Annualised 3-year return+35.0%-63.7%
CRESY leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

CRESY leads this category, winning 2 of 2 comparable metrics.

CRESY is the less volatile stock with a 1.19 beta — it tends to amplify market swings less than BIOX's 1.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CRESY currently trades 81.2% from its 52-week high vs BIOX's 9.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCRESY logoCRESYCresud Sociedad A…BIOX logoBIOXBioceres Crop Sol…
Beta (5Y)Sensitivity to S&P 5001.19x1.94x
52-Week HighHighest price in past year$14.21$5.18
52-Week LowLowest price in past year$8.32$0.35
% of 52W HighCurrent price vs 52-week peak+81.2%+9.3%
RSI (14)Momentum oscillator 0–10041.442.8
Avg Volume (50D)Average daily shares traded271K808K
CRESY leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

CRESY is the only dividend payer here at 8.21% yield — a key consideration for income-focused portfolios.

MetricCRESY logoCRESYCresud Sociedad A…BIOX logoBIOXBioceres Crop Sol…
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target$12.68
# AnalystsCovering analysts1
Dividend YieldAnnual dividend ÷ price+8.2%
Dividend StreakConsecutive years of raises0
Dividend / ShareAnnual DPS$1320.71
Buyback YieldShare repurchases ÷ mkt cap+1.6%+3.0%
Insufficient data to determine a leader in this category.
Key Takeaway

CRESY leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). BIOX leads in 1 (Valuation Metrics).

Best OverallCresud Sociedad Anónima, Co… (CRESY)Leads 4 of 6 categories
Loading custom metrics...

CRESY vs BIOX: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is CRESY or BIOX a better buy right now?

For growth investors, Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria (CRESY) is the stronger pick with 28.

5% revenue growth year-over-year, versus -28. 3% for Bioceres Crop Solutions Corp. (BIOX). Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria (CRESY) offers the better valuation at 9999. 0x trailing P/E, making it the more compelling value choice. Analysts rate Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria (CRESY) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — CRESY or BIOX?

Over the past 5 years, Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria (CRESY) delivered a total return of +149.

7%, compared to -96. 8% for Bioceres Crop Solutions Corp. (BIOX). Over 10 years, the gap is even starker: CRESY returned +68. 4% versus BIOX's -95. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — CRESY or BIOX?

By beta (market sensitivity over 5 years), Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria (CRESY) is the lower-risk stock at 1.

19β versus Bioceres Crop Solutions Corp. 's 1. 94β — meaning BIOX is approximately 63% more volatile than CRESY relative to the S&P 500. On balance sheet safety, Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria (CRESY) carries a lower debt/equity ratio of 66% versus 94% for Bioceres Crop Solutions Corp. — giving it more financial flexibility in a downturn.

04

Which is growing faster — CRESY or BIOX?

By revenue growth (latest reported year), Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria (CRESY) is pulling ahead at 28.

5% versus -28. 3% for Bioceres Crop Solutions Corp. (BIOX). On earnings-per-share growth, the picture is similar: Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria grew EPS -99. 9% year-over-year, compared to -1704. 7% for Bioceres Crop Solutions Corp.. Over a 3-year CAGR, CRESY leads at 6. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — CRESY or BIOX?

Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria (CRESY) is the more profitable company, earning 10.

5% net margin versus -15. 5% for Bioceres Crop Solutions Corp. — meaning it keeps 10. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CRESY leads at 24. 2% versus -1. 1% for BIOX. At the gross margin level — before operating expenses — CRESY leads at 39. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — CRESY or BIOX?

In this comparison, CRESY (8.

2% yield) pays a dividend. BIOX does not pay a meaningful dividend and should not be held primarily for income.

07

Is CRESY or BIOX better for a retirement portfolio?

For long-horizon retirement investors, Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria (CRESY) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

19), 8. 2% yield). Bioceres Crop Solutions Corp. (BIOX) carries a higher beta of 1. 94 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CRESY: +68. 4%, BIOX: -95. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between CRESY and BIOX?

These companies operate in different sectors (CRESY (Industrials) and BIOX (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: CRESY is a small-cap high-growth stock; BIOX is a small-cap quality compounder stock. CRESY pays a dividend while BIOX does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

CRESY

High-Growth Quality Leader

  • Sector: Industrials
  • Market Cap > $100B
  • Revenue Growth > 25%
  • Net Margin > 13%
Run This Screen
Stocks Like

BIOX

Quality Business

  • Sector: Basic Materials
  • Market Cap > $100B
  • Gross Margin > 23%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform CRESY and BIOX on the metrics below

Revenue Growth>
%
(CRESY: 50.4% · BIOX: -16.4%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.